<SEC-DOCUMENT>0001628280-23-036181.txt : 20231102
<SEC-HEADER>0001628280-23-036181.hdr.sgml : 20231102
<ACCEPTANCE-DATETIME>20231102070402
ACCESSION NUMBER:		0001628280-23-036181
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20231102
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231102
DATE AS OF CHANGE:		20231102

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMPASS Pathways plc
		CENTRAL INDEX KEY:			0001816590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39522
		FILM NUMBER:		231370011

	BUSINESS ADDRESS:	
		STREET 1:		3RD FLOOR, 1 ASHLEY ROAD
		STREET 2:		ALTRINCHAM
		CITY:			CHESIRE
		STATE:			X0
		ZIP:			WA14 2DT
		BUSINESS PHONE:		1-716-676-6461

	MAIL ADDRESS:	
		STREET 1:		3RD FLOOR, 1 ASHLEY ROAD
		STREET 2:		ALTRINCHAM
		CITY:			CHESIRE
		STATE:			X0
		ZIP:			WA14 2DT

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Compass Rx Ltd.
		DATE OF NAME CHANGE:	20200701
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cmps-20231102.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:f9d22871-7e5e-44ab-a8a5-580a5cc61036,g:ba79fdb8-e899-425e-807a-2fc32cde64da,d:0e5feec4f8084567ab2969695b2d5871--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cmps-20231102</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-21">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001816590</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cmps-20231102.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001816590</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-02</xbrli:startDate><xbrli:endDate>2023-11-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0e5feec4f8084567ab2969695b2d5871_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington, D.C. 20549 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date of report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 02, 2023</ix:nonNumeric> </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">COMPASS PATHWAYS PLC</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact Name of Registrant as Specified in Its Charter) </span></div><div style="padding-left:1.52pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:32.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.268%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-4">England and Wales</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39522</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-6">33 Broadwick Street</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-7">London</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-8">W1F 0DQ</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-9">United Kingdom</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices; Zip Code) </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">+<ix:nonNumeric contextRef="c-1" name="dei:CountryRegion" id="f-10">1</ix:nonNumeric> (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">716</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">676-6461</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant&#8217;s Telephone Number, Including Area Code) </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Former Name or Former Address, if Changed Since Last Report) </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </span></div><div style="padding-left:0.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.888%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.892%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.916%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.718%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Trading</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Symbol(s)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.008&#160;per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CMPS</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.75pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8201;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt double #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.705%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.02</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Results of Operation and Financial Condition</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On November 2, 2023, COMPASS Pathways plc (the &#8220;Company&#8221;) issued a press release announcing the Company's financial results for the nine months ended September 30, 2023. A copy of this press release is furnished herewith as Exhibit 99.1.</span></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:0.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9.01</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statements and Exhibits.</span></td></tr></table></div><div style="padding-left:0.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.894%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exhibits.</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following exhibits are filed herewith: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.242%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.388%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32023pressrelease.htm">Press Release dated November 2, 2023</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page interactive data file (embedded within Inline XBRL document)</span></td></tr></table></div><div style="padding-left:37.54pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.705%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="padding-left:0.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.364%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.774%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COMPASS PATHWAYS PLC</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: November 2, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mary-Rose Hughes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mary-Rose Hughes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interim Chief Financial Officer</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:15.705%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div><span><br/></span></div></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>q32023pressrelease.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ie8c2c4cacf3f4d0a8c1b52ea2ec1c56d_1"></div><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div style="padding-right:-15.47pt;text-align:center"><img alt="compass_positivextagline-01a.jpg" src="compass_positivextagline-01a.jpg" style="height:90px;margin-bottom:5pt;vertical-align:text-bottom;width:270px"></div><div style="text-align:center"><font style="color:#0a94d0;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:132%">COMPASS Pathways Announces Third Quarter 2023 Financial Results </font></div><div style="text-align:center"><font style="color:#0a94d0;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:132%">and Business Highlights   </font></div><div><font><br></font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:160%">London, UK &#8211; November 2, 2023&#160;&#160;&#160;&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1.65pt"><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:175%">Highlights</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:175%">&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">COMP360 Phase 3 pivotal program ongoing with expanding European clinical sites </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Secured up to $285 million private placement financing with $125 million upfront</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Cash position at September 30, 2023 of $248.0 million</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Conference call on November 2 at 8&#58;00 am ET (12&#58;00 pm UK)</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">COMPASS Pathways plc (Nasdaq&#58; CMPS) (&#8220;COMPASS&#8221;), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today reported its financial results for the third quarter 2023 and provided an update on recent progress across its business.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Kabir Nath, Chief Executive Officer, said, &#8220;We continue to make progress in our COMP360 phase 3 program, most recently with the authorization to commence recruitment in a number of European clinical trial sites. Both phase 3 trials, COMP005 and COMP006, are on track, and we expect to have initial top-line data in less than a year for COMP005. </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:174%"> </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">We also expect to see top-line data in our phase 2 study in PTSD by the end of this year. The August financing, led by specialist healthcare investors, provides a strong financial foundation that permits COMPASS to move forward confidently with our clinical programs, as well as all supporting studies for a potential new drug application filing with the FDA. We also continue to invest in our pre-commercial work to ensure we are prepared for a successful COMP360 launch, if approved.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:154%">Business highlights</font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">COMP360 psilocybin therapy in treatment-resistant depression (TRD)&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:13.02pt">Phase 3 program underway, composed of two pivotal trials with an integrated, long-term outcomes component</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#9702;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.59pt">Pivotal trial 1 (COMP 005)&#58; single dose monotherapy, n&#61;255, topline data expected summer 2024</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#9702;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.59pt">Pivotal trial 2 (COMP 006)&#58; fixed repeat dose monotherapy, n&#61;568, topline data expected mid-2025</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#9702;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.59pt">Long-term follow up in each trial will generate data on duration of response and potential effect of retreatment</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#9702;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:14.59pt">Both phase 3 trials ongoing and on track</font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Additional COMP360 development activities&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:13.02pt">Phase 2 study in post-traumatic stress disorder (PTSD) top-line data expected by the end of 2023 </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:13.02pt">Phase 2 study in anorexia nervosa ongoing</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:13.02pt">Publication of a paper in </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:174%">Psychopharmacology</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> showing the potential of AI technologies to support investigational COMP360 psilocybin treatment in TRD</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">1</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Team Updates</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.22pt">Daphne Karydas appointed to the COMPASS Board of Directors</font></div><div style="padding-left:36pt;text-indent:-14.2pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.22pt">Mary-Rose Hughes assumed the role of interim CFO after Mike Falvey departure&#59; search for a permanent Chief Financial Officer commenced</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Financial highlights</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:174%"> </font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">In August, COMPASS completed a private placement pursuant to which it issued and sold to a select group of specialist healthcare investors 16,076,750 American Depositary Shares (&#8220;ADSs&#8221;) and warrants to purchase up to 16,076,750 ADSs (the &#8220;PIPE Warrants&#8221;) at a purchase price of approximately $7.78 per ADS and accompanying warrant to purchase one ADS. At closing, COMPASS received $125 million in gross proceeds, before deducting placement agent commissions and offering expenses. COMPASS will receive up to an additional approximately $160 million in gross proceeds if the PIPE Warrants are fully exercised . The PIPE Warrants have an exercise price of $9.93 per ADS, which represented a 30% premium to the last sale price prior to the financing, and will be exercisable at the election of the investors beginning in February 2024 for a three-year period.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.22pt">Cash and cash equivalents were $248.0 million as of September 30, 2023, compared with $143.2 million as of December 31, 2022. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#9702;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:9.95pt">Runway lengthened to late 2025 through term loan facility, sales of shares under the At the Market (&#8220;ATM&#8221;) facility and private placement transaction (the &#8220;PIPE)&#8221;.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">Long-term debt was $28.4 million as of September 30, 2023, compared with $0 million as of December 31, 2022.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">Received $116.9 million in net proceeds through our PIPE offering in third quarter.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">Net loss for the three months ended September 30, 2023 was $33.4 million, or $0.67 loss per share (including non-cash share-based compensation expense of $4.4 million), compared with $18.4 million, or $0.43 loss per share, during the same period in 2022 (including non-cash-share-based compensation expense of $3.5 million). </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">Net loss for the nine months ended September 30, 2023 was $85.9 million, or $1.81 loss per share (including non-cash share-based compensation expense of $13.1 million), compared with $60.6 million, or $1.43 loss per share, during the same period in 2022 (including non-cash-share-based compensation expense of $9.8 million). </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">Research and development (R&#38;D) expenses were $21.5 million for the three months ended September 30, 2023, compared with $14.0 million during the same period in 2022. Of this increase, $6.2 million related to an increase in external development expenses as we continue to investigate COMP360 psilocybin treatment in clinical and pre-clinical trials. A further $1.7 million and $0.4 million were attributable to personnel expenses and non-cash share-based compensation respectively, due to increased headcount.  Other expenses decreased by $0.8 million, which primarily related to a decrease in external consulting fees. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">R&#38;D expenses were $60.4 million for the nine months ended September 30, 2023, compared with $45.3 million during the same period in 2022. Of this increase, $10.4 million related to an increase in external development expenses as we continue to investigate COMP360 psilocybin treatment in clinical and pre-clinical trials. A further $4.7 million and $1.2 million were attributable to personnel expenses and non-cash share-based compensation </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">2</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">respectively, due to increased headcount. Other expenses decreased by $1.1 million, which primarily related to a decrease in external consulting fees. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">General and administrative (G&#38;A) expenses were $12.5 million for the three months ended September 30, 2023, compared with $11.6 million during the same period in 2022. This was attributable to an increase of $1.1 million in facilities and other expenses and $0.6 million in non-cash share-based compensation, partially offset by a decrease of $0.2 million in personnel expenses, primarily due to reductions in travel and employee benefit expenses. There was a further decrease of $0.5 million in legal and professional fees. </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:174%">&#8226;</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%;padding-left:10pt">G&#38;A expenses were $38.1 million for the nine months ended September 30, 2023, compared with $33.0 million during the same period in 2022. The increase was attributable to an increase of $2.6 million and $2.1 million in personnel expenses and non-cash share-based compensation respectively. There was a further increase of $2.0 million in facilities and other expenses and a decrease of $1.5 million in legal and professional fees.  </font></div><div style="text-indent:3.8pt"><font><br></font></div><div style="text-align:justify"><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Financial Guidance</font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:187%">Fourth quarter 2023 net cash used in operating activities is expected to be in the range of $9 million to $15 million. This range includes the amount receivable in respect of the R&#38;D tax credit in the UK, the timing for which is uncertain. We are adjusting the full-year 2023 cash burn guidance downward and expect net cash used in operating activities to be in the range of $79 million to $85 million, which assumes the R&#38;D tax credit is received in full in the fourth quarter.  </font></div><div style="text-indent:3.8pt"><font><br></font></div><div><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Conference call </font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">The COMPASS Pathways management team will host a conference call at 8.00am ET (12&#58;00pm UK) on November 2, 2023. </font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Please register in advance </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:174%">here</font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%"> to access the call and obtain a local or toll-free phone number and personal pin.</font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">A live webcast of the call will be available on COMPASS Pathway&#8217;s website at&#58; Third Quarter 2023 Financial Results. The webcast will also be available on the Investors section of the COMPASS Pathways website. The webcast will be archived for 30 days. The call will also be webcast on the COMPASS Pathways website and archived for 30 days. For more information, please visit the COMPASS Pathways website (ir.compasspathways.com).  </font></div><div style="text-align:justify;text-indent:3.8pt"><font style="font-family:'Tahoma',sans-serif;font-size:10pt;font-weight:400;line-height:174%"></font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%"><br></font><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:174%">About COMPASS Pathways</font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">COMPASS Pathways plc (Nasdaq&#58; CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin treatment, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the U.S. Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD). We have commenced a phase 3 clinical program of COMP 360 psilocybin treatment in TRD, the largest randomised, controlled, double-blind psilocybin treatment clinical program ever conducted. Previously, we completed a phase 2b study with top line data showing a statistically significant (p&#60;0.001) and clinically relevant improvement in depressive symptom severity after three weeks for patients who received a single high dose of COMP360 psilocybin with psychological support. We are also conducting phase 2 clinical studies of COMP360 psilocybin treatment for </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">3</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">post-traumatic stress disorder (PTSD) and anorexia nervosa. COMPASS is headquartered in London, UK, with offices in New York and San Francisco in the United States. Our vision is a world of mental wellbeing. </font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">www.compasspathways.com</font></div><div><font><br></font></div><div><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:187%">Availability of other information about COMPASS Pathways</font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">Investors and others should note that we communicate with our investors and the public using our website (www.compasspathways.com), our investor relations website (ir.compasspathways.com), and on social media (LinkedIn), including but not limited to investor presentations and investor fact sheets, US Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that we post on these channels and websites could be deemed to be material information. As a result, we encourage investors, the media, and others interested in us to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on our investor relations website and may include additional social media channels. The contents of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. </font></div><div><font><br></font></div><div><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:187%">Forward-looking statements </font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. In some cases, forward-looking statements can be identified by terminology such as &#8220;may&#8221;, &#8220;might&#8221;, &#8220;will&#8221;, &#8220;could&#8221;, &#8220;would&#8221;, &#8220;should&#8221;, &#8220;expect&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221;, &#8220;objective&#8221;, &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;contemplate&#8221;, &#8220;estimate&#8221;, &#8220;predict&#8221;, &#8220;potential&#8221;, &#8220;continue&#8221; and &#8220;ongoing,&#8221; or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements include express or implied statements relating to, among other things, COMPASS&#8217;s financial guidance, COMPASS&#8217;s business strategy and goals, its expectations and projections about the company&#8217;s future cash needs and financial results</font><font style="color:#808080;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">,</font><font style="color:#808080;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:134%"> </font><font style="color:#808080;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">the anticipated proceeds to be received, if any, from the exercise of warrants issued in the private placement, </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">COMPASS&#8217;s plans and expectations regarding its phase 3 trials in TRD, including its expectations that the trials are on track and the period during which the results of the Phase 3 trials will become available, the potential for these Phase 3 trials or other trials to support regulatory filings and approvals, </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%"> </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">the safety or efficacy of its investigational COMP360 psilocybin treatment, including for treatment of TRD, anorexia nervosa, and PTSD, and COMPASS&#8217;s expectations regarding its ongoing preclinical work and clinical trials, development efforts and innovation labs. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond COMPASS&#8217;s control and which could cause actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">These risks, uncertainties, and other factors include, among others&#58; we will require substantial additional funding to achieve our business goals, including to repay the term loan facility, and if we are unable to obtain this funding when needed and on acceptable terms, we could be forced to delay, limit or terminate our product development efforts&#59; the availability of future tranches under the term loan facility is dependent, in part, on the approval of the lender, achievement of certain milestones and other factors&#59; clinical development is lengthy and outcomes are uncertain, and therefore our clinical trials may be delayed or terminated&#59; our efforts to obtain marketing approval from the applicable regulatory authorities in any jurisdiction for COMP360 or any of future product candidates may be unsuccessful&#59; our development efforts and our business strategy to set up research facilities and innovation labs involves significant costs and resources and may be unsuccessful&#59; </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:134%"> </font><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:134%">and our efforts to obtain coverage and reimbursement for our investigational COMP360 psilocybin treatment, if approved, may be unsuccessful&#59; and those risks and uncertainties described under the heading &#8220;Risk Factors&#8221; in COMPASS&#8217;s most recent annual report on Form 10-K or quarterly report on Form 10-Q and in other reports we have filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) , which are available on the SEC&#8217;s website at www.sec.gov. Except as required by law, COMPASS disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on COMPASS&#8217;s current expectations and speak only as of the date hereof. </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">4</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div><font><br></font></div><div><font style="color:#0695d1;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:154%">Enquiries</font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:160%">Media&#58; Amy Lawrence, amy&#64;compasspathways.com, +44 7813 777 919 </font></div><div><font style="color:#625d5a;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:160%">Investors&#58; Stephen Schultz, stephen.schultz&#64;compasspathways.com, +1 401 290 7324 </font></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">5</font></div><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:58.32pt;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">COMPASS PATHWAYS PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Condensed Consolidated Balance Sheets</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(in thousands, except share and per share amounts)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(expressed in U.S. Dollars, unless otherwise stated)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.746%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT ASSETS&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">248,038&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,206&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income tax</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,010&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,695&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,806&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,651&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NON-CURRENT ASSETS&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,165&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,006&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,224&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term prepaid expenses and other assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,878&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,033&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,294&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CURRENT LIABILITIES&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,248&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,325&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,104&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</font></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,350&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,596&#160;</font></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NON-CURRENT LIABILITIES</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</font></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,431&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - non-current</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,778&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,014&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SHAREHOLDERS' EQUITY&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary shares, &#163;0.008 par value&#59; 61,884,785 and 42,631,794 shares authorized, issued and outstanding at September 30, 2023 and December 31, 2022, respectively</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred shares, &#163;21,921.504 par value&#59; nil and one share authorized, issued and outstanding at September 30, 2023 and December 31, 2022, respectively</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617,165&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458,825&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,466)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,867)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(347,078)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261,146)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders' equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,255&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181,280&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders' equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,033&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,294&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:13.5pt;padding-right:13.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:161%">6</font></div><div style="text-align:justify"><font><br></font></div></div></div><div id="ie8c2c4cacf3f4d0a8c1b52ea2ec1c56d_4"></div><hr style="page-break-after:always"><div style="min-height:25.2pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">COMPASS PATHWAYS PLC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Condensed Consolidated Statements of Operations and Comprehensive Loss</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(unaudited)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(in thousands, except share and per share amounts)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(expressed in U.S. Dollars, unless otherwise stated)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.887%"><tr><td style="width:1.0%"></td><td style="width:45.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.750%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.756%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three Months ended September 30,</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nine Months ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">OPERATING EXPENSES&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,526&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,977&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,379&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,259&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,536&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,559&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,135&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,953&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,062&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,536&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,514&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,212&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">LOSS FROM OPERATIONS&#58;</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,062)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,536)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,514)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,212)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTHER INCOME, NET&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,127&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,206&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,463&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,580&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,080)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) gains</font></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,997)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,064&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,387&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from R&#38;D tax credit</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,983&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,521&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,982&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total other income, net</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,285&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,949&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Loss before income taxes</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,327)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,251)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,546)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,263)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Net loss</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,389)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,371)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,932)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60,579)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange translation adjustment</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(738)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,156)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(599)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,483)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,127)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,527)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,531)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100,062)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to ordinary shareholders&#8212;basic and diluted</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.67)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.81)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.43)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average ordinary shares outstanding&#8212;basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,633,104</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,525,855</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,355,992</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,377,895</font></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:64.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:187%">7</font></div><div style="margin-bottom:6pt;padding-right:18pt"><font style="color:#625d5a;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:187%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cmps-20231102.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f9d22871-7e5e-44ab-a8a5-580a5cc61036,g:ba79fdb8-e899-425e-807a-2fc32cde64da-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cmps="http://compasspathways.com/20231102" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://compasspathways.com/20231102">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cmps-20231102_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cmps-20231102_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://compasspathways.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cmps-20231102_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f9d22871-7e5e-44ab-a8a5-580a5cc61036,g:ba79fdb8-e899-425e-807a-2fc32cde64da-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityCentralIndexKey_5181863b-4114-491a-a2bf-cd6a358df6fd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_90e91a76-6c2a-4d8b-9a36-11e462cf0cae_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4ac079ee-488c-4cc1-ab2d-9eb090832425_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d9b582c1-8fb0-4006-9e9e-5c8a14e28987_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9c23fe22-dcba-499e-9d62-f9d3ad6dc2c4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ac0ceb6f-ea6c-499d-a1a8-d294438827da_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9352d559-2474-415c-905e-f68efec7818f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9dbcc284-33ce-462b-a59f-2f0c7277ba26_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d7edfbbe-80fa-48c1-9145-db990f074f17_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_f9a69c48-2d57-450c-9859-81a0bf93bdd1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_501d58d0-802c-401a-95b2-6571e21ed77d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_2ac6263c-2f22-4e1e-bb97-a7201ec7ff2f_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_84382e4c-035d-445b-b424-370f8199d168_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0d0f9a92-56f9-4af9-90c9-47114721cb6f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_85b57cdb-9450-45c6-8940-7e0e095072de_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_88c86583-b712-48fd-b955-d411e2d4c984_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_be960770-563f-4ab0-9469-792a33cd3d27_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_13bb31ec-7eca-4895-8b39-7f0c03cb4877_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f84370e6-25ad-4672-b179-4b50a9024f00_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e871408d-b763-4844-be5e-d2d379668504_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_d0d66ab1-e941-44c8-9e06-05dab3de98c4_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_69f37673-2687-4dba-97b0-765e799c612a_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cmps-20231102_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:f9d22871-7e5e-44ab-a8a5-580a5cc61036,g:ba79fdb8-e899-425e-807a-2fc32cde64da-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://compasspathways.com/role/Cover" xlink:type="simple" xlink:href="cmps-20231102.xsd#Cover"/>
  <link:presentationLink xlink:role="http://compasspathways.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_aba78e34-8b91-4ded-90b3-41cabd7c8fa6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_DocumentType_aba78e34-8b91-4ded-90b3-41cabd7c8fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_97fee8d8-98f4-4980-8611-88fe251d6f36" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_DocumentPeriodEndDate_97fee8d8-98f4-4980-8611-88fe251d6f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_eba1c63e-141a-46b4-8cf5-2f8f4b4a268a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityRegistrantName_eba1c63e-141a-46b4-8cf5-2f8f4b4a268a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_07e41e2d-8007-4fa9-bb77-e0b801fa4cf9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_07e41e2d-8007-4fa9-bb77-e0b801fa4cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_43498b66-9ec5-4503-944c-bfd0c046497b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityFileNumber_43498b66-9ec5-4503-944c-bfd0c046497b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bff47df0-1fb0-4695-85a4-1f6d9e9c54bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityAddressAddressLine1_bff47df0-1fb0-4695-85a4-1f6d9e9c54bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_48b1bb63-3392-4739-b1f6-d102c2b2137b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityAddressCityOrTown_48b1bb63-3392-4739-b1f6-d102c2b2137b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c96673b4-57e6-4f2b-bfec-4affaac00cf0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityAddressPostalZipCode_c96673b4-57e6-4f2b-bfec-4affaac00cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_c71042bb-401b-4d59-9d88-f32e7393d4e6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityAddressCountry_c71042bb-401b-4d59-9d88-f32e7393d4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_7d6b7a51-9128-4a4e-88c7-c4d3acf5b7a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_CountryRegion_7d6b7a51-9128-4a4e-88c7-c4d3acf5b7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_39252914-30cc-4876-81e9-e111350fcef5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_CityAreaCode_39252914-30cc-4876-81e9-e111350fcef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_37f682c5-e39d-47a1-89a6-4566de59a71f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_LocalPhoneNumber_37f682c5-e39d-47a1-89a6-4566de59a71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_1eb4693f-85f8-411b-924e-251a970e32f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_WrittenCommunications_1eb4693f-85f8-411b-924e-251a970e32f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_74c786b9-e47f-403a-8cab-bb4dfbad1fba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_SolicitingMaterial_74c786b9-e47f-403a-8cab-bb4dfbad1fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9efa36ee-5234-463d-a457-7ba144b49f92" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_PreCommencementTenderOffer_9efa36ee-5234-463d-a457-7ba144b49f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_3043e241-a921-4300-bca7-5965db368e41" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_3043e241-a921-4300-bca7-5965db368e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d41015c1-d330-4fdf-8eb0-d25a76b94afa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_Security12bTitle_d41015c1-d330-4fdf-8eb0-d25a76b94afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cd8c6776-fa49-4188-931b-4bf18b78bf2b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_TradingSymbol_cd8c6776-fa49-4188-931b-4bf18b78bf2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_25922fd5-582b-4ac7-ba8d-ff7b3776b0c5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_SecurityExchangeName_25922fd5-582b-4ac7-ba8d-ff7b3776b0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6e122fec-4335-4fd8-ba32-0ee3b52c8aab" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityEmergingGrowthCompany_6e122fec-4335-4fd8-ba32-0ee3b52c8aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_dd75aee0-d124-4d49-8fc1-24b4e84473ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_AmendmentFlag_dd75aee0-d124-4d49-8fc1-24b4e84473ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_768bda68-6be0-4ce9-88f0-22b9d844e02b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_e8f6a88e-c188-4349-ab6d-cc4a4e9f95a7" xlink:to="loc_dei_EntityCentralIndexKey_768bda68-6be0-4ce9-88f0-22b9d844e02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>compass_positivextagline-01a.jpg
<TEXT>
begin 644 compass_positivextagline-01a.jpg
MB5!.1PT*&@H    -24A$4@  "B0   -6" 8   !TK79+    "7!(67,  "XC
M   N(P%XI3]V   @ $E$051XVNS=L7(;5YXOX!^W1L$XD+CE#9RX!#O8&\RM
M AW,#9P(KDTVV1+]!(9#1*:?P/03#!TA-/0$2^6[-6 RR00FJG:"W6"&+ 77
MP765Z& <., -NC&$-91$\J"!;N#[JE"4:)D 3Y\^?;K[U_^S-Y_/ P
M     %#B'S0!            4$H@$0           "@FD @            4
M$T@$            B@DD @           ,4$$@$          (!B HD
M      ! ,8%$            H)A (@           %!,(!$            H
M)I (            %!-(!            (H)) (           #%!!(!
M      " 8@*)            0#&!1            *"80"(           !0
M3" 1            *":0"            !032 0           "*"20"
M        Q002 0          @&("B0           $ Q@40           "@
MF$ B            4$P@$0           "@FD @            4$T@$
M        B@DD @           ,4$$@$          (!B HD           !
M,8%$            H)A (@           %!,(!$            H)I (
M        %!-(!            (H)) (           #%!!(!          "
M8@*)            0#&!1            *"80"(           !03" 1
M        *":0"            !032 0           "*"20"
MQ002 0          @&("B0           $ Q@40           "@F$ B
M        4$P@$0           "@FD @            4$T@$
MB@DD @           ,4$$@$          (!B HD           ! ,8%$
M        H)A (@           %!,(!$            H)I (
M%!-(!            (H)) (           #%!!(!          " 8@*)
M        0#&!1            *"80"(           !03" 1
M*":0"            !032 0           "*"20"            Q002 0
M        @&("B0           $ Q@40           "@F$ B
M4$P@$0           "@FD @            4$T@$            B@DD @
M         ,4$$@$          (!B HD           ! ,8%$
MH)A (@           %!,(!$            H)I (            %!-(!
M         (H)) (           #%!!(!          " 8@*)
M0#&!1            *"80"(           !03" 1            *":0"
M         !032 0           "*"20"            Q002 0
M@&("B0           $ Q@40           "@F$ B            4$P@$0
M         "@FD @            4$T@$            B@DD @
M ,4$$@$          (!B HD           ! ,8%$            H)A (@
M         %!,(!$            H)I (            %!-(!
M (H)) (           #%!!(!          " 8@*)            0#&!1
M         *"80"(           !03" 1            *":0"
M !032 0           "*"20"            Q002 0          @&("B0
M         $ Q@40           "@F$ B            4$P@$0
M "@FD @            4$T@$            B@DD @           ,4$$@$
M         (!B HD           ! ,8%$            H)A (@
M %!,(!$            H)I (            %!-(!            (H)) (
M          #%!!(!          " 8@*)            0#&!1
M *"80"(           !03" 1            *":0"            !032 0
M          "*"20"            Q002 0          @&("B0
M $ Q@40           "@F$ B            4$P@$0           "@FD @
M           4$T@$            B@DD @           ,4$$@$
M (!B HD           ! ,8%$            H)A (@           %!,(!$
M           H)I (            %!-(!            (H)) (
M  #%!!(!          " 8@*)            0#&!1            *"80"(
M          !03" 1            *":0"            !032 0
M  "*"20"            Q002 0          @&("B0           $ Q@40
M          "@F$ B            4$P@$0           "@FD @
M   4$T@$            B@DD @           ,4$$@$          (!B HD
M          ! ,8%$            H)A (@           %!,(!$
M   H)I (            %!-(!            (H)) (           #%!!(!
M          " 8@*)            0#&!1            *"80"(
M  !03" 1            *":0"            !032 0           "*"20"
M            Q002 0          @&("B0           $ Q@40
M  "@F$ B            4$P@$0           "@FD @            4$T@$
M            B@DD @           ,4$$@$          (!B HD
M  ! ,8%$            H)A (@           %!,(!$            H)I (
M            %!-(!            (H)) (           #%!!(!
M  " 8@*)            0#&!1            *"80"(           !03" 1
M            *":0"            !032 0           "*"20"
M    Q002 0          @&("B0           $ Q@40           "@F$ B
M            4$P@$0           "@FD @            4$T@$
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MR51($0        #@[002 ;H\B(]G^ZDJ'BXJ'PH?-F,14IRF"BA.-0D
M    P"\)) )T:="N HB'N0X@]K7*QLQ2!Q13A11?:A(         8)<)) *T
M?: >SPY3A0\'$4!LL[.HH @         [#"!1("V#<SC62]5%<1!DJ=:I).N
M4H433Y.<JIX(         .P"@42 -@S&X]E!DF&J(.)C+;)U9DDFJ<*)%YH#
M         -A& HD FQJ JZ68%Z]'6F1G7*:JG#B9C_KGF@,         V!8"
MB0#K''3'LT&N*R$*(;(()YZHG @         =)U (D#3 ZWEF+D=RSH#
M     )TFD C0Q. ZGNVG"B$.D_2U"'?T/%4P<:(I         ("N$$@$6.6@
M>KTD\V=:@Q6X2E4UT9+.         $#K"20"E ZDU]40C[(;2S)?)KFH_WRQ
M].<DF=[P[R_N$J:KE[C>?^7;^TD.EO[>JU^IO_]H!]K]+,E$U40
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M8+L&M<TNSWR5*@1Y(L3%"OOT(%7%Q,\V]!&^GH_ZQ[8$         / V HG
M]@QHX]E1DN.L?ZE;RS*SCO[=R^:6<[Y,52UQ:DL          *\CD AT?R ;
MSPY2529<]]*VETF.YZ/^Q%9@C?U]/U4P\2CK#R8^2W(D> L         W$0@
M$>CV(#:>'2?Y:LUO>Y8JB#BU!=AP_Q^FJ@KZ>(UO>Y6J6N*I+0
M+!-(!+HY>&VF*J(@(FW='X99?S#Q>:I@HFJ)         $ 2@42@BP/7^JLB
M"B+2E7UCF/4&$U5+!         #^1B 1Z,Z -9[UDIQF?541+U.%K:9:GX[M
M*\=)CI(\6M-;?I,JM*M:(@        #L,(%$H!N#U7AVE*KRVSH"5I>IPE43
M+4^']YG]5*'$HS7N-X?S4?]<ZP,       # ;A)(!-H]2%6AJDF2IVMXNZLD
M)_-1_UC+%VVSP0W?[M6OMSE/\FJ5O9=";D7;HY<JS/O9FM[R:_L0
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MRS/7E0\'J8*'NQ0^O*VK7 <4I_-1?[I#^UPOU;+H3?:)9_-1?ZB; 0
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ML='<;X5IF4NV /\!:,\?)+T7\'WK>I:_Q.QA<.<O(>W]0596GV#Y*/D(42(
MP,T@2 08$$X8L?14W.==I3%V0KNE;,2(9VI2-*\3_L[3K*Q.)?U#OT1!'-$"
M.J'H4FQQ37CP1/X/GT:2OHD@HL+:P^_@UC=8L0S4_WZ.&!$\S!^.%"::YPEI
MQ;LEH"CQ$6*W.ZW/NIZG+Q 1O?,[S>4GPT ;.-R MGW_1O;"N F6OG%^%?.E
MT)P(K%%@X2/GF!5:<$6$-8#6<X /)(44CR%&[&:.O9;T]X"O_ .IFZ,%42(
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MG'OC/RN%B9*XY0N7 IPY"0P)HB."KS[[M6RC))*VV?_W0I08/P@1 2(#02)
MFA1JO_$9[ :CV]1:RL]F[4G7XCQW>W@E.T&*U&P>?5S/\H+#?HA\(;9-@>SC
M /PPU.UJ=\C35E"8<R@S2*R^^151<,%@SF(IH$64/4RL^JG]@6RR^OZ-ZS?F
M9*'6>*,4^P#G8T\#O:ZZ8=VZCMR?8)A87++<#,!N1<3S*ZO^F;5O^OYU&X\D
M;=C?Z VAHQ8>JHFV66!Z& B_-RKWM:0?,._@^-ZP[ \PKU\0)48-0D2 2$&0
M") 8[L9AV[3')X'3'1=J4H&TI5+X394W[3^5]*7LHFI<2/I+/<LG!FF](-UV
MOY>559&5U28KJ_K:WRJ&#6,7A<%7!*XO0BVPW"%QV\@#!1XZ."9&Y2XQ+1A@
M%1VQ(KWX,''?O3(J?CH $^8>R[IZ\^*2$[:'BHKS*"NK26+V#RFBO&G=ZGM]
MQZ$$M%YG8H6=['8DFPL?E8^]NGJ6G\HFPMYA@OU^JO.MD./YEI&D%VZ?B>^<
M_GS]>0?^<^SV+4D##GV> SR4])Y1\3\XL1,,J\_^29)5FNX/L[)Z@)6]?[.N
M1(E_POHW@A 1('(0) *D1]M#E"N%C8YX)#]1**XD3;J,%IB5U4+2"\-7/)=T
MX#:/ :ZWH8VD8_WVT.-0S8;QNNO#)'=P\KFGXI8!?\^TY?/[H:(Z0A3M<2R_
M8I)?^3T6!@..\%=(Z/M/>CZ&^/Y]Z[?,;:X2]P4+^T]E$PGNQG7=+:*B-6T&
M(L-*U+KIN=VLUG\^1=.%41T+FDWR?O8N#B5]A3 Q>0J%2_U]G7TU:<#Q'^@K
MOS<L^SO,.U@L151$233@FB@QI(CXDZRL/AJHR6\2[2)$!$@$!(D ">$6\H]:
M%A,L!?"U5,T^Z%J,N)1=>J]*TF?U+)^3GAEN:/-WB<B9JTFOTVF4E'J6+R2=
M>"@J5Z"##G=8?-:V7R6ZR&"8&)5[0;0Y,)J'60EHN3PQ;*R^?][S\=0L7?,;
M<YN-PD4"W$\A/9_SJU VN7K+/):4S3"(N6V?LSVX-;J%N/G"1<7S.59;B-,/
MW24M,,:M#S_OL H($]/VGTMU&WW\NO],^2+0(SXT*O?G>I:_PKR#Q3)5-X)$
MN[&V"U'BP4!%B7]5(]S]T?TA1 1(" 2) &E1M'S^P@F&0K&4G]3&3[H4:C@Q
MXF.CXI_7L_P@< IM2 !W<'J? _^1I%77HD0UM_A]I')\&G#3NVWD@9$Z3B</
MP;#R2<1=D)*_5GT6&L"[<=_?*FUSGU.\!1$DNF]4&'ZCW\RC$A"G%)[6I7=A
M>MLE,_???48K&B$,@@CG"A<]M]G4J-REY['Z4G91; N:3K YUT+A4S>_R598
MMD98EIS_K!0^=?--_O/"I7*><YD7>H"5N.L_,>V@^^O7LA,E_AX+FWZ[5T*4
M&*2-U+-\7<_RK]T?0D2 A$"0") (GFYAAT[5_,A#42>>;XG?YS?L966UEHT8
M\4(N*B+>#;<PU?T/3CL7);J#CR/YB<80)'6S$U:TW:1E8W483(S*76):2,A?
M$=""I1_T.>*;[]^VB63M-U*XZ(.[K.D.9!?I_DW.ZUE^VO*[T68@5-O8DTVD
MOTV/;3:6W67512)E2M)CQ-!!.5(<0M]<C;#L,BNK10278>$.N'WG\PBJLB_I
M"TG_R,IJ2=1-2'0>8!EI#G$-6 D2'V9E]0#SFHZUB!(! -X"@D2 ="A:/G^7
MPQ%?BS-?J9HK=11US/V&E6Q2'9Y)(BHBO(M=(P3%($K<R$_DB'V%B[Y0J)V(
MDBB)/<<=NNT;%'U%NF8P8F)4+H)$L/2#28]MYG5=\:ZU1."H.(\B/E@.F:KY
M+O-?WVM !"$0>KT9VL=CPFIM>G);9%4/Z_(3HSI/:4)A\'SITP<C-4+_;[91
M$[F<F41_7T54G\=JHFYNHR:.^420"%81UTG7#))MVN:'F-=\OH8H$0#@%A D
M B2 I^B(1< J+STLT*[TEG17QO:V%"-^7L_RHRY^%R3'N,6S,8@23^7G$#Q(
MZF;7)ML>6!,EL=]8^2'B+K#"8AZ#@!:VX^9:-@?C>1_'4H.YS%TC)14*%U5I
M&:'=I[*) '>CK>^8SG[C^;T3 >S&U*C<31^-Y<8FJ^B(18)],VO?\/.NB>(1
M)5Y?;[R0M"'J7=3^$YNH=<LV:N+W65F=NFQ+ #%#NF:P[*M?2_K1J'C2-H?Y
MAEV)$A&< D#4($@$2(.BY?,GH:+Q>4S5/._BP-M0C'@AZ=-ZEB]P9[@C;2.Q
MQ2!*G,O/+>Q0J9L+M3NT)TIBO[%J2RM,"P;SF0G^"@&P\H<^1GSSW2;OM$YR
M!]"AYB;[65D5L1C<S1U#K;VJ>ZSS?*]Q#P5P__8Q-O2=OEY<L.I+S^\H9MYU
MC;N23;I6UKZ!B5B4N/6'-Z/>(5B-RW\V$?N/U)PE?.G\9T'41(@4JPB)/V):
M<%A%2?P TP8;;U])^C;P:_^,*!$ 8@9!(D#DI!0=T>.ASUD]RY<=V-I*C'BN
M)D7SNL=^.L[*:N)2M11N\VCE_M996=5O^5NYZ"7P6[]I2^>B1/FYA;VO<(<=
M;?M+-M[["X)$2(D)_@H!6"7FOWT:0^Z\KG!1J\\"_<Z8TNX5LCLT?)/I/;Z'
M]S5AQW-]2)/"J-Q>1E)VZSNK]6@(X?2RZ[X/_!"Y*''+-NK=/XAZA__LZ#]/
MU41-9+\88IH+/)#TGE'Q"!)ARW\9E8M8+>QX^U)A+VD]$*)$ (@8!(D \=-V
MX7UB>=OZ#0JUC^IVH>XV-9?R+T8\J6?YI$\IFIWP<.[2L:RRLJHE?2_I*S6I
M6H[5;!X=NK]WV?10T@LG7!S3Y/^)KT5+IZ)$U__X.+PY#O$;G!BZ;91$-MS[
MB444F8N 8S0,"ZOQ=(5I(8 _]'$^V)D@T3%7F,/GD<)%)7S;>N7 K4="\'P'
M 585N7]!CW%K;JO4PWV=)QS)1N!\X43CL:]Q;V,?L5!X$A&5;;D>]:Y@SR\:
M_SDPF(M8L-TOOG1[T,QWH$NLA#ZO7*I>@&UT/0M_>.!$M1#N6R)*! !P($@$
MB!A/&\5%H+KZ.O29=B'>R\IJ*3^IIJ_SI)[ET\1]<"\KJR,7\7#MQ(=?J;GM
M_%A^!3JY&N$<T>4:?![F=BU*7,I/9)Y0!]Q%Q\]#G..Q!6NL"T:8]/=]CO8,
M4?E#KPX;W=QVWW.QFWM^JTW ^<DCP[3QL<T9+W:TZX8V QVR-"S[M*<V*Q(K
M-^1W9^W;W1QLHC1$97+SH&,U4>^(FMB]_VR<_YPG4N5M2O!OW-[TE*\('?FA
M!?^%:>$-7AF5BU M_'B+*!$ 0 @2 6*G:/E\R.B(/@Y]GM>S?!7:R$Z,Z#-"
MP)6DOW21=MJ3/0[<S>6UI'](^E*-V#0/\/I]V1Z0I+1@V4AZ[K'(D:33#@6?
M4[6_P7\88N/10P0)(D7TC[%1N8B[P J+,?L<LT(@O\A[9B/O8K%=Q*#U+%\$
M;,>=S>?='.PPT.MVO4RWCMW'H)]D934W;A^K'MIL*O^B<KFU<4@!YT(V$?7V
M(Q"A#Y)KHL2SQ*I^/6KBG$O)G?G/93W+)_*[[QAJG;N-FDC430B)5;KF5Y@6
MWL JA?<(TW8RWG8E2GP?ZP- +"!(!(@4MR&32G3$J=IO:E^H@YO5KNZ^Q8B3
M$&EW/-OAP$5!W$CZ1LW-Y:X.@Q^QH?3/!<M<THG'(O?5411*=U@[]5#4(E#]
MV_9'<SRX5TR,REUA6C 8TZW&T W6A1M8)^;'?1A#VH@*0\U/]K.RZF)MMZ=P
MT1'/6ERF\SW^'PK@#FM^V>ZY5 $OQ(;$JM]<A,P.XMYEM4]5T,*ZP8G*CB0]
M2[#Z^VJRKVS<?N28+]J)#\TE/5$:*<"O,](O43=)YPRA?,Z"*TP+@7R"E,W=
MC;4O)?T]X"L?2/I7TG0#0"P@2 2(E[:;GD&B(WH\] F>JMF)$5]X++)2(T9,
M(N)55E9C=YMTHT:$^%0V-_]W\@>Z@'\N6*;R*TK,U5$J+2?4;7M[?Z0 A^D>
MHB3F1(KH%58B6"(D@@5CHW(WF!8"^L6X1S8ZB,7F;IT22K0P[T!<4"A,Y(>K
MENL5[^V&@WAXAW_LN36@9?M8]-!N$]E=U%QV\),*HW(/6?MV2SW+"TF?J=T>
M1E>,U.Q';H5E8[YH</]9NOEJE>A/V*9S7M$7@2$/C-H?$1+A3:Q\X@-,V^E8
M^S=)+P.^\J&:2(F($@&@<Q D L1+6\%-$;">;3>U@Z=J=@<V/C?,DQ$C9F5U
ME)752M+W:FZ3[D=8S3%=P*\6+%/Y/3P^=*G*NV"J]C?]C@-M4K?M1XF2V!\.
MC-KV)::%5/Q51/2$FUDGYL=]:).;EL\O%$:P,%) @9);WST-]+JBS1AN='$0
M02+<UC;VW!ANO>X_[:'Y"J-R3[J()NG>>6Y4_)36UBUN7_5 Z:7@O<YC(4SL
MRG\V]2P_4)K1-K<<2OH*82(8\="@S!\Q*]S0'_^$%7K[;=="E @  P1!(D"$
MN,A];41^H:(CCM4(VMH0/%7SM0UY7]$!MF+$RXA]:B\KJ[F+AOBEXD_K-:8G
M^,V"I5"31L47CUU?$_IW>$O='*"N2[4[L"?]>'^PB)!XCEDA(7^5) 2T<!.;
MQ/PX^!Q<_D5 JTCF8G>="TT"O2N4^/&\GN4^WN5['H @$6[K@U:RB_*WY:1O
M%VW<.LYJWV39X4\KC,I]S-JW>UP*Y[G2C9;X3W\2PL2N?*B0]*G2WJ^X+DQD
M?@0^Y@168I[76!=NP4*L2H3$.,991(D ,#@0) +$22K1$7V\)VBJYJ&)$9T0
ML5!S6/R%XHR&>!,KNH$;%RQ+^14EONCBUK!+W=QV<S/4 7?1\?,0!Q:'N(B[
MP H3(5<*4:"AD[G)QJCH<4],9'$(NO;PW5:23@+98!E@S3-5N M7TUB^8P!?
M@X1Q(HR-[,6(4@_3-1NNX\Y#9PBYH?^_2,QFL,-WKF?Y6$VTNZN$?\I6F%BX
M_5P(XS_K>I9/U.P_INP_AVI2.2-LA;8\-"J7=,T  QUGA2@1  8$@D2 R' "
MFS8;QN>!HB,>J-D8:L-9!QNQ"_G;D(]6C/B&$/%8_@28H4#T</N"92F_HL33
MCC;FIFJ_L5D$LG>;>AZQ<0[T<Q 8"U'*%6:%P/XQ[HEM)KYM[7'M,0_4MO?=
MNL1LW:-P8JAG'M?:OM?LAP+XI5W,)7T3:!_@O&^7%MSZ^+%1\<L(?J)5G\S:
M-S)<M+L#A;N$8,6QI$T763X&[C]+-R=_EOA/>2QI;3D?!=@14O/";9BD\\[*
MZGU,&\T8VX4HD4N, - )"!(!XF/:\OE0B^NVASY7:A\)\KX3[JG\;2I'*4;L
M@1!1DBY<!#VX?<&RE#]1XDC2:0>_8>.A'SG,RNHH\OYN).D(KTT7;M(#2$)
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M<T-U7,_R*2E-O/ T*ZO3C@\#I_)SZW@9N-YMHR0>N@@7EK2QR3X;XN! +
MT%^\C_6!Y^ASA8D$,K]']*Q"82+&/P]LZW4*_@>#IM=B1-<'65T"32*]M?NV
M5NO^QT1)["?U+#^M9_E$TL=JA&4Q1A!#E!BO_ZQ<U,V/U43=C#4"W8NN,^$
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M$X^[RH"3"*\E_5W2?]2S_,<>_:Z?^+00&"NQZL^8MA?CXDM)_^'V$;Y&B @
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MZ+'="J-R0V=<@/36X"%%B5,LWDL?FBJ,*)&^;!C^9"7F(D(BO(E%A,2?,2L
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MA474'N:8, A<OWR$)=*=:Q"!&^[(RJA<QDO\!^!=:YV?1-IF\#-O?2#2-0,
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MBG5^V@=1JVL#2^/7G#B1* #TE*RLWL_*ZL^2_A#XU3_4L_Q;O@   *0.@D2
MR#"^G1UE] -C\527-MO@T=""=8QMO64:QJ@CL!A&B$%H -?;T#85[E7@5X\D
M?9F5U8)H2._L"Z9N##_$&IU%]MQR*&E-M,1W^NS<C35=^6SE_*3O6$6=9)X
M7?H)EU\@]CF950: BYY']8UM/KF4W:6L//)]Q=#VV+)*693HZFZ=GOA*"4:W
M<V<'Y\:O>9%:NWK#?_;<M[6^J-7W"UD 0Y^+?B+I?TCZ(/"K7[%/    ?0%!
M(L"PB#EE\ZY83\PGNSY(ZA]HR::CMGX7KB*M5]N^B@-9"((;'[J*5OA41$N\
MD6L1YEZHFPAS,3-1=Z+$D7Z)ED@__6N?/>@X*J*<7TP&8&O+W\B: ;KTDPFF
MA8B9&I9=8-[@%'S/7[$,,(=.<O[LQ&2K //;9<+1[4+X_&GB_I,;O^J<O7^
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M1F'$9,]Z,(\-Y3]?9F4U36&MI'!BQ',G"@6 GN#2,_^;I#]T5(6M&/$57P,
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MYS]K0_\9N[9]U-':Z:R>Y:=TWP!)S"D?2OJ]&O'APPBKB!@1   & X)$  "
M?BZ\HSQ4S,IJ0C0@@+=3S_)3=UBS4GPBI4?N[XNLK"I7QY4:D5=0L9([M)[H
M%U$7J9B[\==+YZ^GBE<(.KKFN\K*ZL+Y[5K2.L2XY&QTX/XF"?GKT,6(DETT
M]PT]"$3D,Q.1RA:Z9VHX]SU'=!O5_'&5E=6YT=QQ/RNKJ8L^GY)-MI&]'W7P
M^I&:M,E/W1IOZ=9WK<5EURZ-3=7M!:;*11+L:YM:9V7U3(U L NV%\$NW+IP
MZ=%_)FK$ZEWZSY5Z&%T3H"]D9?6^I _<W^_5?2KFM_%*C1CQ-5\.  "& ()$
M  " >-FT>'8LNT/+E;K;Y 08!.Y X4#-9GX>:35S]_=4^J?(:^W^5I(N?45(
M<+88ZQ=!UX$0(,;DKY>2)BZRRN,$JKSOZOG8^9?4".\VSG\O]4LDLO5=Q'A.
M(+N-I'<@:?OOXXC;\+LXJ6?Y=,B^[;ZK55^SIO> '>8&5L63MAEB@.B(PV(I
MN\LLA=(464_=_*#+=<XV.KZN11G?KO$NWW:1QXG'KJ_9)I&LV:[4B"+[/D\H
MW"6H+B^)[>L7<>O5M;V!?ZZQ;EM;W> _!Q&MHXY(U0P0Q?K\@9J(A^^[OP_<
MOS](Y"?\*.FOB!$! &!(($@$ +@=#F6@:S:8 &"XN-1=$S4IS5(1>>VKB>IQ
M+/U3Z+4]B-CV:^_JV\;N;SL6C_"&9'QVFI756NX0,S&V MO?1*4Q% #%S.?U
M+%_@U:;K 02)L N5; [G6?M"IV1E-96=<*DB2G^4\\9E5E:%T7??S\KJ*+7T
MJB[R^)'BB93_JRCC"<^+IP.*D'KDUMNQ^,^AWA!()NA#GS.& '0Z1_RCI \5
M9^KE^_!=/<N_Y8L" ,#00) ( ' [>Y@   "ZQ-W"3UGD)?UR$"'%F](7_/GL
MPOGKJ1"3ILB5F@@@*TPAR2Y=LX0@$7;W&PM!(N,S=$UA6#8"^[B_^PNCLN=N
M/IK:7'J=E=7<T"Y#X_/4A*EM]P_<I<85:S$OG'!)"Z [G!CQ#XG_C->2OJUG
M^4N^*   #)'_A@D      .+&;8)_ID8L!!"[OZ[41+D\QQI)<2YIC!CQ5QP8
MMI,-YH4=,/.;K*R(D@B=X,0S5M$1+^I9OL3*T7)JN+XY=+Z5XEQZ*>D9[M&:
M08K)ZEF^5B/(A794]2R?8@: 3ODH\?K_+.EKQ(@  #!D$"0" -P.44L  " :
MKHF\SK &)."OE_4LGXC#U%1X5L_RB8O*"K]@)=!"K N[LDK0WP'>16%8-I&M
M(I\O&G^C:<*V*22=X"4[<S)D,9D3M3[!#7:FDFVD= "X&^\E7/<?))W7L_P5
MGQ$  (8,@D0 @-OA0!:Z)M9#P3&?!J ;G,CK2-+G(EHBI.&SA:1/U1SJ0'Q4
MDCYUWPFND975GNPB=G'Q"79E,\"U!_2[KSV07<KP*TE+K!P]EH+$QUE9C1.>
M1T^%*'$73HALARBQY?J(BUH L"NO):WK6?[7>I:_QAP  #!T$"0"  #$RUZ+
M9RT/NL<MGMWP60':XU)/'8@H6Y"&OZ[51)@@6F)</%=SV(8X[F8LQ5G,AV#7
M_G0CNPL)"!*A"RS3BBX0E"31K_W_[-V_<]Q6OO?Y#V[-QA3O)IN)0_\!X!2=
MLUU%QZ(#*E4[H0J1Z4C*W,K$R'2$$A.W4C$8*MLJ<\NM)WB2-<M$L,&S5>:0
M]20WV!F2-[A/, $VP&FK1R;9IW%^X$>_7U6J.W.'0./'.0? P1??[XW"!MV-
M.GY\AB(H<1$$(_YK^QF+H,1%$(P(P,7?)?TW2C0# / 1 8D NFR-0P#<K:V3
M9^8E*@!/_<F4Q/U:9$N,C;&LQG6);(FM,<V*N,_+M@<- JZ;(%"TL?UL<6@1
MD\E<]RS@3XPYRITQ"KCN9R;K<9?OHX<B*-$&P8AWMY^Q"$JT\5X$(P*HYY^2
M_I\R2_][F:7_Q>$  . C A(!M,%ES>4>MWB?UCBM ( 8S N&-?&2*I8K<\Q1
MK[V>EUFZ(<J.-^%6TK=EEFZ0%=%*R&QQ''^TLOV8\KE +*. ZW[+QW"=NC^\
M5!4,%,I^#X[14&0;?\C7!"/.G3,@*/'A:\8.P8@ :O@/2?]7F:47' H  /Z(
M@$0 -D*_E+ALZ7Z[;-<:S08=Z'N]8[)L $O'9)\;2OI"E'$.;9]#X*7-'HI
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M,WQ=MOB8N00J#41 (NJUFR;:JXVZ01H?0A\T$PP5>VRT\:B%VP1X-Y.9</)
M/WUD>4]!T!9"M]<;692*--D5;>XU;\C."0  @([?&T_NN2<>\/R&.6WHH?8S
M_7CQ/GQL"."N<>4_D[SX;ZJR)/Y3TG])^F>9I?_)T0$ H!L(2 3"N56];$!K
M@;?K4O4"BE8B;%==H8_9Q&'9 5T!-=3.S!3RJV$3E-%$'[?UJ*7;E]*D@=_'
M**L@,*!%;?8RTC4,    :.L],<]P<&D_?+@%H.[X\5^2+C@2  !TT[]Q"(!@
MZCYH/PJ\79=U%W3,/C;OP6+BL/@@\$//I:2KFHL_#GG<T#])7NPX+!XZ"Z%+
M6[Z,</C:OGV+FM C              !=0D BT#ZA,VE=.BR[%GC;Z@;]Q0CX
MFS@L.Z198P$[#;73T'UM$N'8M2Y#(@')             (!E0D B$,ZD[H))
M7H3,DGCIL&SHP)JZV[;B6$HVZ/D499NQF+X&)%Y&.':U^YK)A!K"HY8?,P
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MH;>MSV6;GX3,,(GN,NW"I23Z.,+V/:ZY^%6DTL,N_?\\T'%SR=IZ2<\
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MVY/0P7YEEM[(+6B2+(F8VE?]8#])&D?8QE:7:S8&#8V%H<;*@JX!
M     .@B A*!\*YJ+K<5>+M<@G &(3?,9 :[<EA%C"R)(\?ER9*XY#QD1Y3<
MRH?'Z.\GD0YG6G=\#I7!T92VKQML>DD/ 0            !T$0&)0'B7=1=,
M\B)8)D(3A%,WZ"^-$$PW<5@V>$"B.7X?'%:QHCC!9&BO0[EE1WP?NARR&8,>
M-]2/;;=QX+!X*\LU!]XN              ""(2 1"&_BL.Q:X&UK;99$N656
M>Q(I^^#(<?EG(8-.T5[FO#]S7$V,@%:7#(X?3'GST%S&HDG [2(@$0
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MBJ0QW60IC.66==!'>[,9=QY)>N*XGS&X9&J=!-RN04NW"P            "
MH A(!.*8."P[:/&V!2W;7&;IC3I0MME3ED1*-_><*8'\Q'$U7<B.*$4HU^QA
M? QY'%T"R<F0"             #H+ (2@3A< DP&@;=MTN)MD]PRK:TD>3&,
M=(Y]!!..(F3$1 -,"=^QCS;2@?;\(4:Y9M-7'M=<_#9P8*?+V$A (@
M      "@LPA(!.)P"3 )&J!69NFYI*N:BZ^8K&\AM^]$TJW#*H8Q3K YCF\=
M5[,B:6S*Y:)?QG(OU?PV1G9$TZ<?.^YK# .'92<!C]\C26G-Q6]C!',"
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M$KN%AU6EJC(E$I38'2=R"YB;NHK59CUD1[Q5-\HUWP8.\'09IR=T'0
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M]B.?^XFDKSVN<D72KTE>#.E9G?=#F:7CR+_I^GLQLR.NJ=T9" <MWC8
M         *(A(!%HQMAAV1AEFUVS. Y#;Z"G+(DC4VHU&A-T]M;S:G],\N*0
M;M6XNH&\;\LLC1H<F^3%2&[ECZ7N9$=T'7-#C\L3N@X             H"\(
M2 2:,7%8]G'H,KTF:.[6817#2,=QY+C\BL('*MUU?(?R'Y3X39(7YR:3')I1
M)RBT4(0RY[-,&W']S6C9$0V7[2U"EL).\F+'C"5UQP,R) (
M>H. 1* !)CCFRF$5PPB;.798=BO)BT&$XSB16WEI27H28UOOV/:AW#,\?BJ5
M=&X"I!#_G$XD_;# (H6D@2F3'M-8#@%T1K0@2I-QU65[0V</=>EO[^DY
M         ( ^(2 1:(Y+5JP8 6=CQ^6'D8ZCC\"H<>S2S3/GL?"\SA5)?TWR
MXJ2A?5IJIO2R3?;+1H(13;#JEN-JWH;,.'B'D<.RMXYC;>CQF.R(
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MY5@SE/2CXVJN)$7+[&BRP/[JL(JBS-*-P'WVVF$57Y=9.J9U @
M  #ZA R)0+-<RG6N1"K'ZY)A;$5Q,CFJS-)#N6<97)&?DK9UMO_&!$^]#?@S
MWZDJX[Q/UUL>)CNFCTR!H\C!K*[M-'1V1-?QEW+-             (#>(2 1
M:%"9I2>JLH[5-8RPF6/'Y?=-)K$8? 3:/6DR8*_,TJ'"!B6N2/H^R8M+DS4/
M_7<B]U+-'V)F\S-!E,\<5G$587M=Q@G*-0,             >HF 1*!Y+EFR
MGH0.]BNS]%)N 7(QLR1.)/W@854C4RZV$28H\=O /_-8TH\F,'$4,6@4$25Y
M<2@_9<"'D3=]Y+C\./!Q77,\KF1'!             #T$@&)0//&CLL/(VRC
M:^G3F%D21Y)N'=>Q(FG<9)">*4']E8=]F>>Q/I9R'C<9B F_3$GW;SRLZI4)
M3(ZUW6MRRXYXJ_#EFEV#K E(!             #T$@&)0,/*+#V76]GF_4C;
M^,%A%3&S)-[(3Y!FJL!9UBSVY4320%(1X>=65 6!_9KDQ7F2%T.R)G:7">KS
MT7Z+,DM'D3??]?=.(I1#=AEC*-<,             .@M A*!=G#)YO4XR8M!
MA&T<.2X?+4NB">1[[V%53Y*\&#79,$PPZ,#3_MA*)?THZ3K)BQ."$[O%G*L3
M54&FKH:1MWT@M^R(/L:J>=LX=#RV8UHI             *"O"$@$VL&U?.<P
M] :663J1>Y;$PXC'="@_Y8Z_,Z5O&U-FZ4V9I3N2OFW@YY_H8W#B>9(7HT@!
ML*AOK"JHU-4K$Q ;T\AQ^;<1RDN[C+>W)F :             (!>2LJRY"@
M;>B,>3&1M.6PBC^'#L0Q@7E_=5S-GR,$#$VW=R#I9P^KNI4T:" XZZY]VI"_
M@#-7'R1-))U+NHQQ?,S^WY>M\:8-YZCA]C&2])V'515EEFY$WG8?_37H^&)*
M8?_-814_E%FZ+P              >HJ 1* MG;$J _JCPRI>E5DZBK"=EY(>
M.ZSBO<GV%^NX'DKZQL.J;B6ME5EZTX*V\DA5)KEO6MB4/TBZ416D*%4!BY)^
MS[(Y;[^F07"S_WE@_KMM$&9A?G\BZ:0-YZPC8\BLO\0.[DSRXEQN@;9ORRP=
MMGP\^<NR!\T"             /J-@$2@31TR+VY4E3:NXZK,TK4(VSB4>]#3
M%_."TSQN[R-5@6D^,@H6JC(EWK2DO0Q494M\3.]YT'M)A[':7$-M84/2KYY6
M]VV9I8>1M]_'N!(Z.^(C29<.8W3TK),              ,3V;QP"H%7&#LL^
M-D$]0959.E85F.<B6K"3"1X<JLIPZ"K53,:_II59.C%!J*_H.@]Z(NGG)"\N
M3=GQ7C'!B+[:Y?L&@A$?>1@3WD8H!;^C^L&(4<<]              ":0D B
MT"ZN 2O[D;;3]7?2)"]B;:M,B51?OY<F>3%N4Z,QI;K_K*I<,N[W6-)?D[R8
M)'FQUH<=F@E&7/&PNEM5P;NQ[7O8_E&$[1PY'ML3NB              H.\H
MV0RTK5/FQ432EL,JHI1#]K"=MY+68I8_-H&$SSRM[FV9I<,6MI^!JL#6E-XT
M5_32Q)[/M<]RY)+T%Q.\&W,?UB3]K>U]T636_&O?Q@L         =TORXH7%
MGYV667K&T0+HDP  X%_]B4, M,Y8;H%^(TF#"-LYDO2SP_(KJ@+GAK$.;)FE
M0Y-1SD< U[,D+]2V(",3C+IARG>/5&4%Q-V^-P&<PYB!L9X>O'T'(WX;.QAQ
M9KSS,1:%MM^!;00     H+62O/A-TOJ</WM>9ND11PN@_[;$GLU^2R+X":!/
M @" 3U"R&6B9,DO'DJX<5K$5HQRM"7Q[[[B:9R8@+*8=5=D9?7C6MO+-L^VH
MS-(U25\[MJ>^>R)I8@+\.B% ,.+;)C)%FJ#9+<?5O"JS]#+P=@X<M_-#Z&T$
M             * M"$@$VFGLN/PHTG;N>UA'U$ H$Q@T\+C*U@8EFOTE,'&^
M5!T)2@P0C%AXZL=U]L.U[]]&&C]<C\\A70P             L"P(2 3:R36
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MFNGQJLS2481SL";W[(@C ?Z\IG0SVLAD$5@D,(3)?=">@?9;;_'+6#[2
M0 B;DGY*\N(-AP(  ,"?/W$(@'8KLW2<Y,5(5<:]ND:J@NU";^N-";YSS>SV
M39(7)R;K8LQC?6ZRXDWDMTSN]Z9\\[X)?.Q+V[PQQ^H/Y\EDQ)LM63VP7.V-
MI/.9W[!M Q-)A^9W]R5]YV$7MY*\V"BS]#S&\31MY,2QK]^ET6!$,R8\\;"J
M6/LP]G"\+[EZP:-IZ>:G' JTS**!LIL<,M">@4[8E73:I@U*\F*3?@<  (#
M]LQ]YY=EEEYS.    -P0D ATPTAN07[/DKP8QPCP,P&40TE;CJLZ2?)B+78
M7\"@Q&>2-I*\&,8*<&O23+#BU"3B[XZ2O#A1%5B6.JYR7Q$"X4PPHN\V)TE%
MP\&(&_*3+?"'&..7Z?NN8]=(@'^[25[LEEEZS*$   "![25Y\;)E+V%W.2T
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M_/NRS-(CC@YHST#K7.N/0;=W657SV0GW+/[F6 0D @  P/Z9[T"+!24R!P<
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MK6]'-&D$%F0R/E#P$'VWAQ8(X+0.ID_RPBIPOH59$6S:=,SKZYG'?KBLXQ0
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MFGQ)<T&_0!_;%WT7GSB6W8N;>5DZ;.Y+6G>=,B_1NFHU<%^C+W&]!Q@WZ;\
M& /@T<S<X;Q PFW-+U$]+QCP[*X@,\NRS39SEXV6:^YA/[2IO+.>Y,7V@A5R
MHITG$UCYI>H%)7YJ&J#XQAR;T]#!K0 60T BP(WMC<GZ=RX_ 7P_)GFAAH,2
MSTV0W(G"9(V;9DL<JLJ6>+[D;6AV_T_H5>&9LMJ':G<Y[=2TAP%G#&C,2U43
M5S83+KM)7NRV[8'=?+WZ1OV;O+4)%EUT\LBJK$87,F'.G'_;DFE+E36BQ_T"
M_6FC]-W^/?.=)7GA5#;,-G"^I2\/NCS>KHN@0:[W .-FU'&3_@MP#6<,@ >G
MFC_79U-=I4YVQ*EY'U3;9$-NI%QS7_MAF:5')CN@3>6=18[KO'GJ:WD,'#5!
MB9^9<[3M:;5[DO:FI9TIZPRTP[]Q" "8;',['E?YHPER;'J?!I+>!OR95-*O
M25X<)GGQB):$T)*\>)3DQ:&DG]7N8,2IK20OQIPYH+%KX;6DYPLL\J9-F2R2
MO'BGJNST:@_/S9GL)H5V+8_5JN7?4KZB^_<"O>T7 %K/YN7#JGGQ4_>:Q@L#
M@.L]0/\%P!@ V#U_;5K,Y6X[_,Z\N<M=B]^?]QSH_:.T)>B'-L_->[;S_.89
M?M[?>O_(O<S2BS)+OU15M>G,XZI7);U.\N*W!^8G $1"0"* Z85_(NEKCZL<
MFRR%3>[339FE0TG?!OZI;U25<=ZA)2$4DY'STK2W+GEFMAU ,]?"8]E_O;@J
M4^:@X?%N-<F+7V09C-=A-N=EUW+RR&;BZ,X2+"UWO4#;[?M]P++T"_0#?;>_
MURV;<[MWUQAF.7Y16@G+_MS/]1Z@_P)@# "F'YK;/!_M/= NY\T77CPT5VCF
ME><] ^X^\/N;%L_]Q_3#6L_F<FD;G[#)4'@4L*T?EUGZN:3/555<\!7XN"[I
MG<DH": AE&P&,'O1'YM2L,\\K&Y%TB3)BT'3)8W++#U,\N)<5?G8E4 _\UC2
M7Y.\^"!I?]G+.,.?CI1GGN<PR8N)R5P*(+Z79F+!)O!C+\F+TZ;*)9J A9]D
M5_+C/F?Z9&)F7HD&4U[TM\B[>ZPJ /2A\S(-X)@WZ=/+[(AEEEXG>6'SITT&
M-:W3+P#Z[A*=UR-)+^;\Z7:2%^MEEEY\<IV:=[Y//UFF32@O#NZ# <9-^B\
MQ@#$9E.V>;/F_R;9!;;-*]N\K?OG''<M]Y%^N-BS^85Y-I\7<#BWI+?EQX-1
M/G(WOW$FZ<!LUYZJN9L]QU6_2/)BTV1C!! 9 8D /KW@#Y.\6).TY6%U;0I*
MG)C]FBAL8->6JC+.;R6-",""PP/4FJI Q"<]V)T5LR]D$06:N09>)'GQ4M(;
MRT5>FZ#$)EXBO=;B$T?3R:+C%@<RW'5>; ,['@Q(-!-?\[YDM?VJNHTN-#]P
M:+/![=ND7P#TW25R;''=FEZ[#C[Y[_.T-G!^@2#;-B*8LCNXWJ-/SZ#+-F[2
M?P&NX8P!"/7\-6\^]Z$YP3V+]<]S.F<]VTE>K-XSCSQWOM+C1_'+U@^/+<[O
M9I(7VV66GLYI/]&R6"YR+SDSI_!\)D!Q4_4R8&XG>?&ZS-*7#"M 7 0D KC+
MCOP%[K4I*/%&TD:2%X<*7_;VF:0=\UN'YK>!N9*\>"1II/BEF0M)TW:Z(?_9
M1)^8<6#"608:N08>F3(=-B48UE5-XCR///YM:[$O'H\E'72P#/&LNIFF9EF5
MP&PHP-2'M@<UK=,O /KN$MU/G"5Y<6IQ/[$G\_+ -G"^J>S,GMOT\S)+CV@I
MX'H/+,^X2?\%N(8S!B#@\]=UDA?'>GCN;S7)B]U/GZ<LRB5?6+;#4U7!^O>M
M:]4\[WWZ^^ORDZ&1?GAWVSA-\N+,XACOZN$LE//FE:_5@H\'/PE05)(7>Z;=
M+1*<^,(D83AE= 'B^3<. 8 [+NPWJH(2;SVM<AJ4N-&2_=N7](7'_7MHO[^3
M=)GDQ<@$F@'W/30]2O)B).E2\8(1WTKZJLS2I,S2C3)+!^;?(TE_EO2MI"N/
MOS?B3 .->B[[; ][9C(GID4F$)Z66?K4X\11(V5#39#AJ>.QL9EPZ_)+/IMS
MO-I >Y4)\EVE7P#TW25C\])HW1QGV^O405_:-,T#7.^!I1LWZ;\ UW#& (1D
M,V^X6:-M6@4#FD"PTQK](%JYYB7NAS;SO;LFN^ ?6)9K;N5'[F66'I59^E32
MOR\XG_":(06(BX!$ /==S"\E#=3?H,2)I#5)'R+\W#0P\3S)BR&M"Y_<],\&
M(GXG_YD)[_)>TI_++!V667IRWQA09NEAF:5KDK[V-!9L)7DQX*P#C5W[+A9\
M0']SWX1%(+:31Y\'R*+49*8LF\FCO7NN(=L6VW[6\2_OSSRW'Y^VZ1< ?7<)
M'<ON X=% A*/.[#?-B6\* 4.KO? \HV;]%^ :SAC $(_?]5IAUX"$BW_=KO&
M-=YGEORE[(<FR_2\9_.'@@YW/;4_-7@,KDT9YL]M[SU-]E  D1"0"."A"_FY
MJDR)OK0M*/&FS-*!JBQPMQ%^\K&D'Y.\(&,BF@I$O)7T=9FE.R;HV+:OC%65
M<2X\;,.0LP\T>NT[D'V0R+KFEQ/V-2;.*R,R]3)0<%V3DT<V@1WK]V01LYDX
MZGKI2-NOI?=B!M":TC-[] N OKN$]Q+7LGPI9LHHS3N_I^:CB;:S&6<)=@77
M>V")QDWZ+\ UG#$ +7G^6I\-LC+_^:'V<;%@FYR6;;[/ZDR&?.O,>_1#+VR2
M#]PW!S+O'%UTI;RQ.;=/+?^<YW8@(@(2 <R[B$]494?SI55!B68?#^4OV,K&
M8U'*>9DG*IH(1)2J;* ;)KBP3C^Y5)4UU;6?[- *@,8]7>!O7T0JIVG[96*H
M29"F)R)L)H]V/[F>V$SNV0:-M/E>]%KV0;0QRVZ\H%\ ]-TE9AOL_L;CNIHV
M[R6<5+V((^ 57.^!Y1DWZ;\ UW#& ,2ZIB[2'N:UC87F"BW+-F\OV#9/Z8=>
MV)S+/V0%-!]KSMOV3GWD;H(2CSRV&0 >$) (P.8B/E:8H,1!B_;QLLS2#4FO
M(O[LM)3S99(7XR0OUFAM_97DQ5J2%V-5D[$Q Q%O)7U;9NE@D:R(]_23&[D'
M):XD>4%0(M#L->]"TLL%%GD38;-6+;?=^Y>LEA,PH=EFFIH]3KL6Q^W83!IV
MG>U$Z5Z,LALF2'>/?@'0=Y?X7N),]@&G#[D.4#(KU#[;O(23"'H%UWM@F<9-
M^B_ -9PQ +&>K>?-[^W>\Y]=GM4766;V-^>U39_/@4O=#\T\OTT0WMX#Y^L^
M7:RZ<^&KS0#P@X!$ +8W-6-)/WA<Y8JDGY.\&+9L/T>2_J(JFUPL*Y*>2?I;
MDA<G;0K4A)>'DITD+R:2_F;.<TS3K(B''OO(C=S++M/&@>:O=XN6;G[=@LT.
M%5BWVX+S<:'Y$WN?9D1<AG+-L_MA>_[?A2S_:B8;W[3HV/2V7X"^V_.^VY?S
MZ^J@8_ML\])L/<F+*,$U25Z\2/+B'4UQ*7"]1U<Q;M)_ :[AC %P9!GDOYGD
MQ:IY]GWH@[_KFL%Y-F6;MRW;YS'],/K]UET?NC^XSI ?N<^TU:Z<:P U$9 (
M8)&;WGU);SVO]L<6!B6>EUDZD/2MJNQR,3U1%:AYF>3%/N6<N\ED0QPE>7$I
MZ:^2MB)OPJVDKWUD1;ROC\@M0'F#5@*TPO..;>^J[V 5,_'QNB7[9S5Y-+/=
M\[[ /0OQ]6]#]V;7L@]:69?T4XC )K/.=^8WZ!<-["O#-GVW1WVW#VRR=/BX
M]K6I31_++N/"Z]!9/\W+OM>J7BS]$NAE#MIS+5JFZSWZ=2_ N$G_Y?D 2]].
M>6:'Q^>O>78U/]"LUAINC^H  "  241!5(=EMF6;S?5\7ELXI1]ZO=\ZU?S$
M []_Z&[.T::']E;WV&U*^D75/ WC$-!S!"0"6/3&9J@P08FC%N[KH:K J?<-
M_/QC2=]+NC;EG"EQVP$F&^*)JFR(WYGS&-M;26LFJVE(+ED7MV@M0"NN<V?J
M7F8BWV4PWK7H?-B\K-LV$U[+E!UQ=G]L U\V504V>7O):-;UD^9/V-$OPB'8
MAK[;M[[;]?N(:[F]I#@U&8*[QO;>Z:=0P34FJ.;=)WWGEYF,).CGM6A9KO?H
M'\9-^B_/!UAV/+/#AWD9"J=M;=MB/77->_[;T_PY2Y_EFNF'']G, ^]:'HN+
M4.?(W'O]9,:+S20O?O+\$S;WDA<"$ T!B0 6%B@H\;LD+\8MW-?+,DMW)'TA
MZ:JAS7@FZ:\F:^)ADA=DEVN1)"\VS'FY494-\4E#FU)(^J+,TJ$IJQR\;\BA
MM#G9/X'67.=>MN0AW'8;O)7R,A,>;0M0L9T\VIOS-ZY!(FULJXMD6I,^OF3<
M]=!6]B3]UD![6:9^<6'9]D'?[4+?729'#2W;9)L^TOSL$U*5F>$GW\$NIF_\
MI#]F?IC^W@N:9>>N1=P'H^_W GT>-^F_/!^ >P>>V>F3,9^M3RW.P4/7T6N3
M3:^NN66;+=K[,?TPV/W6W(!5\_''O'GE(,_J9H[FTWNR[20OO%3+6. C?@(2
M@8@(2 10]^9F*/]!B<^2O)BT,5"IS-))F:5KDEXI?AGGJ<>2OI'T:Y(7YZ:D
M\QJM,;Y/2C+_:L[+2D.;<ROIVS)+-\HLG43^;9??([ 6:(\VE&ZVG0S;3/+B
MC>,8OFXFCMJ81<AFPN>UYG]U?FPF*OMV_WD@NY>94ZN2WIF)K>T:;64OR8M?
M)+VA7P1G,QFX:B8O0=]M>]]=IG-[MN"YG6HJ*T;L>Z=IL(MS6TSR8C7)BW>:
MGXGC=9(7E/'LUK6(^V#PS-G=<9/^R_,!EAO/[/3)V%R?H9P"S2R#(GWU&_KA
MXFP^!GTCBWEEWQMF[K7N._[;DGYS^3#5!#3:9JTD(!&(B(!$ "XWGT/Y#TK<
MDC1I:Z!=F:4C58%4;QO>E%152>>_F>#$$9D3PYK)A'BI9DLRSYJ69SYLZ/<G
MM R@%]?S4S5<NME,:-D&-.R9()6%OT0UV2]^4TLGCCR4OYPZZG&3?2K[\J]3
MVZI>;/XCR8L7]TV0FY>6+Y*\>)WD1:EJHFR3?A&%[63@ZU"E_$#?1=1KSD&7
M=]@$8BZR#WM)7I1ULW"9Y?XA^ZPS+Q@KNW,MXCX82_+,V<MQD_[+\P&6?FSC
MF9T^&9M-V>9YR[MRF;?T_F$:U^*%S\V\?3\ML]1KP)X)XIQW3U?[PU03R/B+
M[.:!NOYQ)- Y?^(0 '"\V1LF>2%5985]226=)WDQ*+/TO(7[?"EI:$I,CU0%
M438I-?^^2_+B2M*)I$F9I2>T4*>;Y$>2!I)VS/]]W*+-^R!I:-HB /APH.IE
MS7J#VW D^VQ6VZI*>AZKFG0Z-2^Y/AW+-\W?KFM^.8JV.));F9NSNXY%C^X]
M+Y*\>*JJQ,>B5E5EF)2/K"NF[6W2+[PX7> <_I+DQ9'9O^,[]F\ZR7G:Y[Y
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M_S+]G_W^GFKS[B5Y3][SM6\GV7[/GS<;<,H\3_*T&S<GJ_!D^^73#RJ^Q$F
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MP,:/9[YG=T[B/#R?\[_W4<I,IA]S?YD^W'GMPZEW\^&@TI@"JS#V"A*!.;V
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M(K!9@]ZDW4X)$Q\LP=-YTS^79Y9TWJAC\'9*@+B?I%F"I_0\97EFQR
M    4$60"&SFX#=I=U)BP&9)GE*;Y"CBQ'4]WJ81XL,L=DGFZUZFS(AX8@\!
M         #=!D AL]B X:?>2'&3QR^5>)TY<CV-K&2/$I,S,>="-FR-["0
M      "X28)$@"QMF)B4./%92IQX:D\M_7&TE1(@[F5Y9M^<$B("
M (,2) ),!\0RH]U^?[NUA$_Q39*3_O:L&S<7]MI2'#,[_>UAEB]HG1XW0D0
M        8'""1("W!\82F>VEA(EWEOBIMKF*$T_LN;D='SNYBA ?+/%3%2("
M         ',E2 3XT""YO$LYO\O+)*?I9U$T@^*-[/_;2;:S&@'BE! 1
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MC@QG\4N2(\LR P        #+3) (<-,#ZV;,FLCPVI1EF8_,A@@
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M         ,"F$B0"K.+@/6EOIX2)TUD4S: X/P)$         (!W$"0"K,N
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M2 0           "J"1(!          " :H)$            H)H@$0
M     *@F2 0           "J"1(!          " :H)$            H)H@
M$0           *@F2 0           "J"1(!          " :H)$
M    H)H@$0           *@F2 0           "J"1(!          " :H)$
M            H)H@$0           *@F2 0           "J"1(!
M  " :H)$            H)H@$0           *@F2 0           "J"1(!
M          " :H)$            H)H@$0           *@F2 0
M  "J"1(!          " :H)$            H)H@$0           *@F2 0
M          "J"1(!          " :H)$            H)H@$0
M *@F2 0           "J"1(!          " :H)$            H)H@$0
M         *@F2 0           "J"1(!          " :H)$
MH)H@$0           *@F2 0           "J"1(!          " :H)$
M        H)H@$0           *@F2 0           "J"1(!          "
M:H)$            H)H@$0           *@F2 0           "J"1(!
M      " :H)$            H)H@$0           *@F2 0           "J
M"1(!          " :H)$            H)H@$0           *@F2 0
M      "J"1(!          " :H)$            H)H@$0           *@F
M2 0           "J"1(!          " :H)$            H)H@$0
M     *@F2 0           "J"1(!          " :H)$            H)H@
M$0           *@F2 0           "J"1(!          " :H)$
M    H)H@$0           *@F2 0           "J"1(!          " :H)$
M            H)H@$0           *@F2 0           "J"1(!
M  " :H)$            H)H@$0           *@F2 0           "J"1(!
M          " :H)$            H)H@$0           *@F2 0
M  "J"1(!          " :H)$            H)H@$0           *@F2 0
M          "J"1(!          " :H)$            H)H@$0
M *@F2 0           "J"1(!          " :H)$            H)H@$0
M         *@F2 0           "J"1(!          " :H)$
MH)H@$0           *@F2 0           "J"1(!          " :H)$
M        H)H@$0           *@F2 0           "J"1(!          "
M:H)$            H)H@$0           *@F2 0           "J"1(!
M      " :H)$            H)H@$0           *@F2 0           "J
M"1(!          " :H)$            H)H@$0           *@F2 0
M      "J"1(!          " :H)$            H)H@$0           *@F
M2 0           "J"1(!          " :H)$PM,>,P  !1A)1$%4
M    H)H@$0           *@F2 0           "J"1(!          " :H)$
M            H)H@$0           *@F2 0           "J"1(!
M  " :H)$            H)H@$0           *@F2 0           "J"1(!
M          " :H)$            H)H@$0           *@F2 0
M  "J"1(!          " :H)$            H)H@$0           *@F2 0
M          "J"1(!          " :H)$            H)H@$0
M *@F2 0           "J"1(!          " :H)$            H)H@$0
M         *@F2 0           "J"1(!          " :H)$
MH)H@$0           *@F2 0           "J"1(!          " :H)$
M        H)H@$0           *@F2 0           "J"1(!          "
M:H)$            H)H@$0           *@F2 0           "J"1(!
M      " :H)$            H)H@$0           *@F2 0           "J
M"1(!          " :H)$            H)H@$0           *@F2 0
M      "J"1(!          " :H)$            H)H@$0           *@F
M2 0           "J"1(!          " :H)$            H)H@$0
M     *@F2 0           "J"1(!          " :H)$            H)H@
M$0           *@F2 0           "J"1(!          " :H)$
M    H)H@$0           *@F2 0           "J"1(!          " :H)$
M            H)H@$0           *@F2 0           "J"1(!
M  " :H)$            H)H@$0           *@F2 0           "J"1(!
M          " :H)$            H)H@$0           *@F2 0
M  "J"1(!          " :H)$            H)H@$0           *@F2 0
M          "J"1(!          " :H)$            H)H@$0
M *@F2 0           "J"1(!          " :H)$            H)H@$0
M         *@F2 0           "J"1(!          " :H)$
MH)H@$0           *@F2 0           "J"1(!          " :H)$
M        H)H@$0           *@F2 0           "J"1(!          "
M:H)$            H)H@$0           *@F2 0           "J"1(!
M      " :H)$            H)H@$0           *CV_Y]I<+B.Q>BG
) $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139988864801280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 02, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  02,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMPASS PATHWAYS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">33 Broadwick Street<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">London<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">W1F 0DQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">GB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">676-6461<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">American Depositary Shares, each representing one ordinary share, nominal value &#163;0.008&#160;per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CMPS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001816590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>cmps-20231102_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cmps-20231102.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001816590</identifier>
        </entity>
        <period>
            <startDate>2023-11-02</startDate>
            <endDate>2023-11-02</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="c-1" id="f-21">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001816590</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">COMPASS PATHWAYS PLC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39522</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-6">33 Broadwick Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-7">London</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-8">W1F 0DQ</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="c-1" id="f-9">GB</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="c-1" id="f-10">1</dei:CountryRegion>
    <dei:CityAreaCode contextRef="c-1" id="f-11">716</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">676-6461</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">American Depositary Shares, each representing one ordinary share, nominal value &#xa3;0.008&#160;per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CMPS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ @#AB5ZK$(A8S 0  (@(   \
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M4$L! A0#%     @ @#AB5\?)^:CM    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ @#AB5YE<G",0!@  G"<
M !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " " .&)7K[4"#F,$  ":$   &               @($,"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ @#AB5Y^@&_"Q @  X@P
M  T              ( !I0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "
M.&)7EXJ[',     3 @  "P              @ &!#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " " .&)7JL0B%C,!   B @  #P              @ %J$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ @#AB5R0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ @#AB5V60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cmps-20231102.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://compasspathways.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cmps-20231102.htm">cmps-20231102.htm</File>
    <File>cmps-20231102.xsd</File>
    <File>cmps-20231102_lab.xml</File>
    <File>cmps-20231102_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cmps-20231102.htm": {
   "nsprefix": "cmps",
   "nsuri": "http://compasspathways.com/20231102",
   "dts": {
    "inline": {
     "local": [
      "cmps-20231102.htm"
     ]
    },
    "schema": {
     "local": [
      "cmps-20231102.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cmps-20231102_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cmps-20231102_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2022": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "report": {
    "R1": {
     "role": "http://compasspathways.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cmps-20231102.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cmps-20231102.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CountryRegion",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country Region",
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://compasspathways.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-23-036181-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-036181-xbrl.zip
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M.;M-XSXZ"A+Y+CE"#(&0W3).FQFNA2?S]!CB#SD$"$))I/:*P]S!*. ?&@0
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MX(PIH/Y*/ 8%,-NY^&7WZC6X/6![./9).!?:\:UD)VM;QDO1"XS(!IX-T=]
M.:S,LSUX843<*R.22E'_99Z"5HH6I&:@#G?(&:@DE'//;A(>IO9737+?1#)
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MLS^AUS4TJ)=MJ+=XX/GZ#N4H-^"IA3+ +KH]2%'Y Z.BX[;Z<F5A'13;HUF
M/-O>]:UKVMKZ-@,=4ZLU$,^T)E)(0ZQ+ _%>6@DFFL2JPZ@[KQMT>YN*!OSE
MHOH\PQMC2CCO_G24[.AX ;>CYCB_]\_>/=IF%A\(#4(2[0PC$ADAACI!)//6
M!>5UM.D@M[]&._3ZZY2^K?VDJ@/4.'CLX6SM#]+[4K;/%K.UK?%&Q"_S(NRO
MCG6U.D6NVNH$S.W2@NY.)QAUA+J&<+O+RC>#VT;6XI *6\M39/P.ZKP*[\KP
M(XZYF5$10 =-C(Z22*,IT2EC1.L(/&$AC>(TJ3^ [:4!/GX-',_EF<7PKFSS
M=O,1%GG'1-G^;%>0@;/,IP((D\P2F3J4M8\)3HL8CY.6I]H.TL)KJ+VD(,8K
MA<%,CD()'[!.J]=5O27^$_(/\^JA;.O-O J04062 0]8)5%%9+2&.*<4 >HT
M9=%*'\T)A/$_G>BE$SEVG9R.YU'(YGU>P,\/*P=UUC&A79H2 SXA,L'JT4CI
MB8N!>BI3:90[@4;^1.PEB&3L@CB2P5%D_VT(R'KS_(,%.;#,Q2A5B)2PZ"B.
M?"8A.K$2=]-@P/A$NE/(X!7H7GI(QZZ'H9R.21AS_/M+?5\]EIG4CCF7"B*$
MX40J@2,;ND\"KO4\=YR)DXP.+X![B4)])Z(XDL\Q2>*N:EI;_"=?;^<[;])4
M"2R.$@4ISG?<X6 'GD@;H[6>4A_IZ51Q@-U+&/H[$<;QK(Y)&\^54.85HY([
M1R1EN F)(28@.5%P0*&+(&'8DO0UU%YZ,-^)'HYA\LQ*>':Y6T=59:9"ZI1-
M&#&,(PL8.2ZBO2)>!F%Q(84GARTX#N#Z=:3H>)-_/'GGSGJGV1KL=MS"F2SA
MADDBJ,?12JN4: :& &-,)#1ZB,FPI'^%UB_G(VY#'DW=F5/>O:HH[I95N5_V
M"!53S7'% \($+&4L(]I8G+B2- V0&*M8')3VOR+V2_V(NX^#*#QS^G^K\[:%
M<EZM5@]EOGMKU60,'"YK1,1U340F&,Y6AN.XQ1-FC:(@^,!"\%78?D(8<>]Q
M.)EG5L.GJLA]WN;EXB>+=\QMD2GIE4X=CEU212Q<A"7:6RQAG0S1V8!KX&%-
MZ)>8_70PXM[B0!K/+(*[&CH%0^EA^UZM>R5;_Q+1C\Q M"(%( D7DLA4!&)E
MHHAREDGI)%+"!XGAV]C]1#'B_N*):!V7.#XTS0/47\<BJ!3 )2/6<(;T4$J<
MMXHD)DV"$ZD&R4XID1<>]!/*B!N/)Z7XW!,*^ ><%#>,N_N\+2 +DE&6>$:"
M$)3(&'!:!$=)X,@&CH_2QH'3R5\0^\EAQ"W'012>.?WWM>V^-ONT6;FJR'S0
M/E6X%HH6@Y<=#49TC1 7F79*N\B'-9T/X/HE?L0MQ>/)&\E#_^[)+VVY@.TK
M>)X8SF/HOOWCZ+7UBCBK XE1.8%Q.>J'=1->0^VG@1&W$0=3.8J&\KL5U N4
M\K_JZK%=SKLO LM-E@+#,+I&N!!)-XYI#$-P0@&$2[C7UI[B'=2KX/T^>!IQ
MB_%4Q)Y9'V^QP@E=E?.^L(LL!)58 )S*&,<Z." 9.N)$Q[$&!BVE$@/7F@=P
M_30PXI;C\>2-8E28H^>U+3Y@8?OT;]AD*M4NV%23U&$4TH/IOM2CA'-G @8
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M#IX^PO^9ID@CG3M@^#C6&O"Z"2?6P >Y'@RY14'40P1P6#CPQZA)4 9D.AP
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M>#6XEBCD0'8>FCJ*0ZE)%6T@F$I62\%IR_?C4XD4S9 YI-X<E.%*%IP:3>J
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M&N::]IJ=?"GMY?WO?UW^"SY\_K .9@X[:1^=2;03X!,=2$]AZE^Y2Y&3.RI
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M%U!+ 0(4 Q0    ( ( X8E<66/3IUP\  !)W   1              "  0
M  !C;7!S+3(P,C,Q,3 R+FAT;5!+ 0(4 Q0    ( ( X8E>==?]V;@(  'D'
M   1              "  080  !C;7!S+3(P,C,Q,3 R+GAS9%!+ 0(4 Q0
M   ( ( X8E<*6CCK*@H  ")<   5              "  :,2  !C;7!S+3(P
M,C,Q,3 R7VQA8BYX;6Q02P$"% ,4    " " .&)7L4GU,J &  "<,   %0
M            @ $ '0  8VUP<RTR,#(S,3$P,E]P<F4N>&UL4$L! A0#%
M  @ @#AB5\#;[!KJ)P  N*L! !8              ( !TR,  '$S,C R,W!R
D97-S<F5L96%S92YH=&U02P4&      4 !0!( 0  \4L

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
